Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Integrated Biopharma Inc (OP: INBP )

0.1909 -0.0191 (-9.10%)
Streaming Delayed Price Updated: 2:46 PM EDT, May 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,000
Open 0.1808
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.2100
Today's Range 0.1808 - 0.1909
52wk Range 0.1806 - 0.3800
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023
Via ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023
Via ACCESSWIRE

Performance

YTD
-22.87%
-22.87%
1 Month
-16.60%
-16.60%
3 Month
-9.10%
-9.10%
6 Month
-20.89%
-20.89%
1 Year
-46.97%
-46.97%

More News

Read More
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023
Via ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2023
Via ACCESSWIRE
Integrated BioPharma Announces the Sudden Death of Its Executive Chairman and President
Via ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2022
Via ACCESSWIRE
Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2022
Via ACCESSWIRE
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2022
Via ACCESSWIRE
Integrated BioPharma Announces Change in Directors
From Integrated BioPharma, Inc.
Via AccessWire
Topics Cannabis
Exposures Cannabis
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2022
From Integrated BioPharma, Inc.
Via AccessWire
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2021
From Integrated BioPharma, Inc.
Via AccessWire
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2021
From Integrated BioPharma, Inc.
Via AccessWire
Exposures COVID-19
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2021
From Integrated BioPharma, Inc.
Via AccessWire
Exposures COVID-19
Multiple Miners Make Their Way In for Q1 OTC Market Index Rebalancing
Via Benzinga
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2021
From Integrated BioPharma, Inc.
Via AccessWire
Exposures COVID-19
Integrated BioPharma Announces Launch of Investors Website
From Integrated BioPharma, Inc.
Via AccessWire
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.